Ryan Allway August 25th, 2021 Psychedelics The partnership will further industry growth for naturally derived psilocybin VANCOUVER, BC / ACCESSWIRE / August 25, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the “Company” or “Havn Life”) a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs that... Read more
PharmaDrug Announces Clinical Research Collaboration with The Johns Hopkins University to Evaluate DMT in a Comparative Clinical Study
August 25, 2021
Ryan Allway August 25th, 2021 Psychedelics Toronto, Ontario–(Newsfile Corp. – August 25, 2021) – PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) (“PharmaDrug” or the “Company“), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs,... Read more
Led by Dr. Mark Kimmins, the MAB will Help Guide the Development of the Company’s Mental Health Platform
August 23, 2021
Ryan Allway August 23rd, 2021 Psychedelics, Top News VANCOUVER, British Columbia, Aug. 23, 2021 (GLOBE NEWSWIRE) — KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0) , a company focused on consolidating medical clinics and becoming a North American leader in mental health treatments, is pleased... Read more
Psyence Group Announces the Commencement of Online Sales and Distribution of “GOODMIND” Products
August 19, 2021
Ryan Allway August 19th, 2021 Psychedelics TORONTO and CAPE TOWN, South Africa, Aug. 18, 2021 (GLOBE NEWSWIRE) — Psyence Group Inc. (CSE: PSYG) (“ Psyence ” or the “ Company ”), a life science biotechnology company pioneering the use of natural psychedelics in mental health and well-being, is pleased to announce the commencement of online... Read more
Silo Wellness Announces $3 Million U.S. Sales and Distribution Partnership for Marley One Line of Functional Mushrooms
TexasUncategorized August 19, 2021
Ryan Allway August 19th, 2021 Psychedelics, Uncategorized TORONTO, Aug. 19, 2021 (GLOBE NEWSWIRE) — Silo Wellness Inc. (“Silo Wellness ” or the “ Company ”) (CSE: SILO) (OTCQB: SILFF) (FRA: 3K70), a leading global psychedelics company, today announced a $3 million national distribution agreement with Texas-based distribution and advertising company One Light Enterprises... Read more
Revive Therapeutics Signs Exclusive Worldwide License Agreement For Medicinal Mushroom Ganoderma Lucidum To Treat Cancer
August 18, 2021
Ryan Allway August 18th, 2021 Psychedelics Novel discovery and research originated from Universidad Central del Caribe and St. Jude Children’s Research Hospital Medicinal mushroom compound with anticancer activities that have minimal effects on normal cells Showed superior potency against aggressive breast cancer with potential to treat aggressive malignancies such as... Read more
Ryan Allway August 18th, 2021 Psychedelics TORONTO, Aug. 18, 2021 /CNW/ – Wake Network, Inc. (“Wake” or the “Company“), a global leader in naturally-derived psilocybin production and the developer of genomics-based integration therapies, is pleased to announce that MagicBio Research Inc. (“MagicBio“), a wholly-owned subsidiary of Wake, has received an exemption from... Read more
Ryan Allway August 18th, 2021 Psychedelics, Top News NAPLES, Fla., Aug. 18, 2021 /PRNewswire/ — Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a patient-first biotechnology company developing novel therapeutic drugs to improve the quality of life for cancer patients, Chief Executive Officer, David Johnson, today is issuing an open letter to shareholders. Dear Fellow Shareholders: As... Read more
Ryan Allway August 17th, 2021 App, Psychedelics, Top Story Silo Pharma’s notice of allowance paves the way toward clinical trials for its psychedelics delivery platform using homing peptides. Silo Pharma Inc. (OTCQB: SILO), a development-stage biopharmaceutical company focused on the therapeutic potential of psychedelics, recently announced that the U.S.... Read more
OMID Makes Strategic Investment Into Psychedelic Medicine
August 12, 2021
Ryan Allway August 12th, 2021 Psychedelics ALPHA, N.J., Aug. 12, 2021 /PRNewswire/ — Today, OMID Holdings, Inc. (OTC Pink: OMID) is pleased to announce its initial investment to gain exposure to the legal psychedelic medicine industry. The investment made in the second quarter with KetaMD, which offers at-home medical ketamine treatments, marks... Read more
